View by Specialty

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

Motility News

SPONSORED CONTENT
January 17, 2025
2 min read
Save
Medicare selects 15 drugs for second round of price negotiations, including semaglutide

Medicare selects 15 drugs for second round of price negotiations, including semaglutide

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS.

SPONSORED CONTENT
January 14, 2025
2 min read
Save

Prucalopride still effective in CIC despite older age, unhealthy BMI or renal impairment

Prucalopride still effective in CIC despite older age, unhealthy BMI or renal impairment

Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, according to data.

SPONSORED CONTENT
December 19, 2024
3 min read
Save

Constipation Awareness Month seeks to ‘normalize conversations about digestive health’

Constipation Awareness Month seeks to ‘normalize conversations about digestive health’

Although constipation affects millions of people worldwide, it remains one of the least discussed health concerns due to social stigma, according to a press release from the International Foundation for Gastrointestinal Disorders.

Trending

PC0125Qi_Graphic_01_WEB
January 10, 2025
3 min read
Save

Drinking coffee in the morning reduces the risk for death

SPONSORED CONTENT
November 13, 2024
2 min read
Save

Angiotensin receptor blockers ‘may not be safe,’ worsen outcomes for celiac disease

Angiotensin receptor blockers ‘may not be safe,’ worsen outcomes for celiac disease

PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease, including anemia, iron deficiency and “continued mucosal damage in the small intestine,” according to a presenter.

SPONSORED CONTENT
November 07, 2024
2 min read
Save

Atmo capsule may offer ‘potential replacement’ for nixed SmartPill in motility disorders

Atmo capsule may offer ‘potential replacement’ for nixed SmartPill in motility disorders

PHILADELPHIA — An ingestible gas-sensing capsule from Atmo Biosciences showed “substantial agreement” with the discontinued Medtronic wireless motility device for measuring regional transit times in gastrointestinal motility disorders.

SPONSORED CONTENT
October 11, 2024
2 min read
Save

No difference in stool frequency with B. lactis HN019 vs. placebo in constipation

No difference in stool frequency with <i>B. lactis</i> HN019 vs. placebo in constipation

Daily consumption of Bifidobacterium animalis subsp lactis HN019 did not increase complete spontaneous bowel movements per week vs. placebo in healthy individuals with functional constipation, according to a study in JAMA Network Open.

SPONSORED CONTENT
September 26, 2024
2 min read
Save

New guideline highlights ‘individualized approach’ in management of chronic constipation

New guideline highlights &lsquo;individualized approach&rsquo; in management of chronic constipation

An updated clinical practice guideline from The American Society of Colon and Rectal Surgeons underscored the need for collaborative, cross-specialty care to achieve “optimal patient outcomes” in chronic constipation.

SPONSORED CONTENT
September 20, 2024
2 min read
Save

‘Bad guys’ in the gut: Archaea overgrowth linked to severe constipation

&lsquo;Bad guys&rsquo; in the gut: Archaea overgrowth linked to severe constipation

The prevalence and severity of constipation was significantly higher in patients with intestinal methanogen overgrowth, underscoring the importance of diagnostic and treatment strategies specific to archaea overgrowth, researchers wrote.

SPONSORED CONTENT
September 19, 2024
1 min read
Save

Vanda’s tradipitant falls short for gastroparesis as FDA requests ‘additional studies’

Vanda&rsquo;s tradipitant falls short for gastroparesis as FDA requests &lsquo;additional studies&rsquo;

The FDA has issued a complete response letter to Vanda Pharmaceuticals indicating it cannot approve the company’s new drug application seeking approval for tradipitant as a treatment for gastroparesis.

SPONSORED CONTENT
September 04, 2024
3 min read
Save

Q&A: Advise patients of ‘healthy diet, lifestyle choices at any age’ to avoid bloating

Q&amp;A: Advise patients of &lsquo;healthy diet, lifestyle choices at any age&rsquo; to avoid bloating

Occasional bloating is common in most individuals, but for some, aging can contribute to an increase in gas as gastrointestinal motility slows, leading to an uptick in bloating and other GI symptoms.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails